Utah Medical Products Inc当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名113/208位。机构持股占比非常高,中期看,股价处于平稳状态。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。
Utah Medical Products Inc评分
相关信息
行业排名
113 / 208
全市场排名
270 / 4582
所属行业
医疗设备与耗材
压力支撑
由于公司未披露,未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
0
位分析师
--
评级
0.000
目标均价
0.00%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议
Utah Medical Products Inc亮点
亮点风险
Utah Medical Products, Inc. develops, manufactures and markets a broad range of disposable and reusable specialty medical devices. The Company has a particular interest in healthcare for women and their babies. The Company’s broad range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians’ offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a patented uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device. The Company produces medical devices for blood pressure monitoring and blood management, electrosurgery, labor and delivery, neonatal intensive care, urological care and women’s pelvic health.
Utah Medical Products, Inc. develops, manufactures and markets a broad range of disposable and reusable specialty medical devices. The Company has a particular interest in healthcare for women and their babies. The Company’s broad range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians’ offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a patented uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device. The Company produces medical devices for blood pressure monitoring and blood management, electrosurgery, labor and delivery, neonatal intensive care, urological care and women’s pelvic health.
公司代码UTMD
公司Utah Medical Products Inc
CEOCornwell (Kevin L)
网址http://www.utahmed.com
常见问题
Utah Medical Products Inc(UTMD)的当前股价是多少?
Utah Medical Products Inc(UTMD)的当前股价是 56.610。
Utah Medical Products Inc的股票代码是什么?
Utah Medical Products Inc的股票代码是UTMD。
Utah Medical Products Inc股票的52周最高点是多少?
Utah Medical Products Inc股票的52周最高点是65.560。
Utah Medical Products Inc股票的52周最低点是多少?
Utah Medical Products Inc股票的52周最低点是51.260。
Utah Medical Products Inc的市值是多少?
Utah Medical Products Inc的市值是181.38M。
Utah Medical Products Inc的净利润是多少?
Utah Medical Products Inc的净利润为13.87M。
现在Utah Medical Products Inc(UTMD)的股票是买入、持有还是卖出?
根据分析师评级,Utah Medical Products Inc(UTMD)的总体评级为--,目标价格为--。
Utah Medical Products Inc(UTMD)股票的每股收益(EPS TTM)是多少
Utah Medical Products Inc(UTMD)股票的每股收益(EPS TTM)是3.543。